These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15195021)

  • 21. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)].
    Gabuev A; Oelke M
    Aktuelle Urol; 2011 May; 42(3):167-78. PubMed ID: 21604233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between benign prostatic hyperplasia and lower urinary tract symptoms and correlation between prostate volume and serum prostate-specific antigen in clinical routine.
    Hedelin H; Johansson N; Ströberg P
    Scand J Urol Nephrol; 2005; 39(2):154-9. PubMed ID: 16019770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Review of Adverse Events Related to Prostatic Artery Embolization for Treatment of Bladder Outlet Obstruction Due to BPH.
    Moreira AM; de Assis AM; Carnevale FC; Antunes AA; Srougi M; Cerri GG
    Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1490-1500. PubMed ID: 28795212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of benign prostatic hyperplasia by family physicians.
    Toguri A; Barkin J
    Can J Urol; 2010 Feb; 17 Suppl 1():26-34. PubMed ID: 20170598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive methods to evaluate bladder obstruction in men.
    Elterman DS; Chughtai B; Lee R; Te AE; Kaplan SA
    Int Braz J Urol; 2013; 39(1):4-9. PubMed ID: 23489514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study.
    Antunes AA; Carnevale FC; da Motta Leal Filho JM; Yoshinaga EM; Cerri LM; Baroni RH; Marcelino AS; Cerri GG; Srougi M
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):978-86. PubMed ID: 23580116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The relationship between intravesical prostatic protrusion and pressure flow study findings in patients with benign prostate obstruction/lower urinary tract symptoms].
    Park SC; Lee JW; Rim JS
    Actas Urol Esp; 2012 Mar; 36(3):165-70. PubMed ID: 22018947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progression.
    Trachtenberg J
    BJU Int; 2005 Jun; 95 Suppl 4():6-11. PubMed ID: 15871730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1010-1. PubMed ID: 16094029
    [No Abstract]   [Full Text] [Related]  

  • 31. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower urinary tract symptoms in the older male.
    Hsieh K; Taylor JA; Albertsen PC
    Conn Med; 2003 Sep; 67(8):487-90. PubMed ID: 14587129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting.
    Mochtar CA; Kiemeney LA; Laguna MP; van Riemsdijk MM; Barnett GS; Debruyne FM; de la Rosette JJ
    Urology; 2005 Feb; 65(2):300-5. PubMed ID: 15708042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathophysiology and therapy of benign prostatic hyperplasia].
    Sampson N; Madersbacher S; Berger P
    Wien Klin Wochenschr; 2008; 120(13-14):390-401. PubMed ID: 18726663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary bladder characteristics via ultrasound as predictors of acute urinary retention in men with benign prostatic hyperplasia.
    Ho CC; Ngoo KS; Hamzaini AH; Rizal AM; Zulkifli MZ
    Clin Ter; 2014; 165(2):75-81. PubMed ID: 24770808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary retention.
    Hernández Hernández D; Tesouro RB; Castro-Diaz D
    Urologia; 2013; 80(4):257-64. PubMed ID: 24419919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bladder catheterization and a plasma prostate-specific antigen in patients with benign prostatic hyperplasia and complete urine retention.
    Dutkiewicz S; Stepień K; Witeska A
    Mater Med Pol; 1995; 27(2):71-3. PubMed ID: 8935194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benign prostatic hyperplasia: mode of presentation and postoperative outcome.
    Khan M; Khan AL; Khan S; Nawaz H
    J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.